{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-017757","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2023-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.605488+00:00","generated_at":"2026-06-08T19:18:58.601913+00:00","sec_items":["5.02","9.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Iradimed adopts clawback policy for executive compensation recovery effective Oct 2, 2023","bullets":["Board adopted Incentive-Based Compensation Recovery Policy on Nov 2, 2023, effective Oct 2, 2023.","Policy mandates recovery of erroneously awarded incentive-based compensation from current and former executive officers.","Recovery triggered by an accounting restatement; no misconduct required for clawback.","Policy complies with Nasdaq Rule 5608 and SEC Rule 10D-1; indemnification of executive officers prohibited."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-017757","json":"https://secwatch.observer/filing/0001558370-23-017757.json","markdown":"https://secwatch.observer/filing/0001558370-23-017757.md","text":"https://secwatch.observer/filing/0001558370-23-017757.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023017757/0001558370-23-017757-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023017757/irmd-20231102x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T19:18:58.601913+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}